Literature DB >> 19615405

Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.

Paola M Barral1, Devanand Sarkar, Zao-zhong Su, Glen N Barber, Rob DeSalle, Vincent R Racaniello, Paul B Fisher.   

Abstract

The innate immune system responds within minutes of infection to produce type I interferons and pro-inflammatory cytokines. Interferons induce the synthesis of cell proteins with antiviral activity, and also shape the adaptive immune response by priming T cells. Despite the discovery of interferons over 50 years ago, only recently have we begun to understand how cells sense the presence of a virus infection. Two families of pattern recognition receptors have been shown to distinguish unique molecules present in pathogens, such as bacterial and fungal cell wall components, viral RNA and DNA, and lipoproteins. The first family includes the membrane-bound toll-like receptors (TLRs). Studies of the signaling pathways that lead from pattern recognition to cytokine induction have revealed extensive and overlapping cascades that involve protein-protein interactions and phosphorylation, and culminate in activation of transcription proteins that control the transcription of genes encoding interferons and other cytokines. A second family of pattern recognition receptors has recently been identified, which comprises the cytoplasmic sensors of viral nucleic acids, including MDA-5, RIG-I, and LGP2. In this review we summarize the discovery of these cytoplasmic sensors, how they recognize nucleic acids, the signaling pathways leading to cytokine synthesis, and viral countermeasures that have evolved to antagonize the functions of these proteins. We also consider the function of these cytoplasmic sensors in apoptosis, development and differentiation, and diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615405      PMCID: PMC3165056          DOI: 10.1016/j.pharmthera.2009.06.012

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  163 in total

1.  Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses.

Authors:  Kiyohiro Takahasi; Mitsutoshi Yoneyama; Tatsuya Nishihori; Reiko Hirai; Hiroyuki Kumeta; Ryo Narita; Michael Gale; Fuyuhiko Inagaki; Takashi Fujita
Journal:  Mol Cell       Date:  2008-01-31       Impact factor: 17.970

2.  Cytosolic antiviral RNA recognition pathway activates caspases 1 and 3.

Authors:  Johanna Rintahaka; Daniel Wiik; Panu E Kovanen; Harri Alenius; Sampsa Matikainen
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

3.  NLRX1 is a regulator of mitochondrial antiviral immunity.

Authors:  Chris B Moore; Daniel T Bergstralh; Joseph A Duncan; Yu Lei; Thomas E Morrison; Albert G Zimmermann; Mary A Accavitti-Loper; Victoria J Madden; Lijun Sun; Zhengmao Ye; John D Lich; Mark T Heise; Zhijian Chen; Jenny P-Y Ting
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

Review 4.  MDA5/RIG-I and virus recognition.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Curr Opin Immunol       Date:  2008-02-12       Impact factor: 7.486

5.  IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence.

Authors:  Kristi Peters; Saurabh Chattopadhyay; Ganes C Sen
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

6.  Isolation of endoplasmic reticulum, mitochondria, and mitochondria-associated membrane fractions from transfected cells and from human cytomegalovirus-infected primary fibroblasts.

Authors:  Petros Bozidis; Chad D Williamson; Anamaris M Colberg-Poley
Journal:  Curr Protoc Cell Biol       Date:  2007-12

7.  The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I.

Authors:  Sheng Cui; Katharina Eisenächer; Axel Kirchhofer; Krzysztof Brzózka; Alfred Lammens; Katja Lammens; Takashi Fujita; Karl-Klaus Conzelmann; Anne Krug; Karl-Peter Hopfner
Journal:  Mol Cell       Date:  2008-02-01       Impact factor: 17.970

8.  Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity.

Authors:  Peter Gee; Pong Kian Chua; Jirair Gevorkyan; Klaus Klumpp; Isabel Najera; David C Swinney; Jerome Deval
Journal:  J Biol Chem       Date:  2008-02-11       Impact factor: 5.157

9.  HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation.

Authors:  Atsushi Okumura; Tim Alce; Barbora Lubyova; Heather Ezelle; Klaus Strebel; Paula M Pitha
Journal:  Virology       Date:  2007-12-20       Impact factor: 3.616

10.  Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation.

Authors:  Min-Jung Kim; Sun-Young Hwang; Tadaatsu Imaizumi; Joo-Yeon Yoo
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

View more
  76 in total

Review 1.  RNA helicases: emerging roles in viral replication and the host innate response.

Authors:  Arnaz Ranji; Kathleen Boris-Lawrie
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

2.  Molecular cloning and functional characterization of feline MAVS.

Authors:  Hongxia Wu; Xiaozhan Zhang; Chunguo Liu; Dafei Liu; Jiasen Liu; Guoqing Wang; Jin Tian; Liandong Qu
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 3.  Activation of RIG-I-like receptor signal transduction.

Authors:  Annie M Bruns; Curt M Horvath
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-11-08       Impact factor: 8.250

4.  Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses.

Authors:  Kristin M Bedard; Myra L Wang; Sean C Proll; Yueh-Ming Loo; Michael G Katze; Michael Gale; Shawn P Iadonato
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

5.  ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling.

Authors:  Linlin Gao; Helen Coope; Susan Grant; Averil Ma; Steven C Ley; Edward W Harhaj
Journal:  J Biol Chem       Date:  2011-09-01       Impact factor: 5.157

Review 6.  Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts.

Authors:  Yvonne Nitschke; Frank Rutsch
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

7.  MDA5 localizes to stress granules, but this localization is not required for the induction of type I interferon.

Authors:  Martijn A Langereis; Qian Feng; Frank J van Kuppeveld
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

8.  Inhibitory effects and related molecular mechanisms of total flavonoids in Mosla chinensis Maxim against H1N1 influenza virus.

Authors:  Xiao-Xia Zhang; Qiao-Feng Wu; Yun-Liang Yan; Feng-Ling Zhang
Journal:  Inflamm Res       Date:  2017-11-24       Impact factor: 4.575

Review 9.  Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.

Authors:  Kun Huang; Ophir Vinik; Kam Shojania; James Yeung; Rachel Shupak; Michael Nimmo; J Antonio Avina-Zubieta
Journal:  Rheumatol Int       Date:  2019-08-02       Impact factor: 2.631

10.  Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo.

Authors:  M Del Rocío Baños-Lara; Arpita Ghosh; Antonieta Guerrero-Plata
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.